LIST OF NEW MOLECULES |
| |
|
|
CODE |
Product NAME |
|
|
|
|
AG-51 |
4-Cyano-4-(4-Fluorophenyl)cyclohexane-1-One
CAS No : 56326-98-8
Application : Levocabostine |
|
|
|
|
AG-52 |
Cyclohexanecarboxaldehyde
CAS No : 2043-61-0
Application : Intermediate of Fosinopril and Melagatron
|
|
|
|
|
AG-53 |
Cyclobutanecarboxylic acid
CAS No : 3721-95-7
Application : Intermediate of Butorphonol |
|
|
|
|
AG-54 |
[(2,6-Dimethylphenyl) Amino Carbonyl Methyl] Chloride
CAS No : 1311-01-7
Application : Ranolazine |
|
|
|
|
AG-55 |
1-(2-Methoxyphenoxy) 2,3-Epoxy Propane
CAS No : 2210-74-4
Application : Ranolazine |
|
|
|
|
AG-56 |
1-(2,6-Dimethylphenyl) Amino Carbonyl Methyl] Piperazine
CAS No : 5294-61-1
Application : Ranolazine |
|
|
|
|
AG-57 |
4'-tert-Butyl-4-chloro butyrophenone
CAS No : 43076-61-5
Application : Ebastine, Terfenadine |
|
|
|
|
AG-58 |
4-(Diphenylmethoxy) Piperidine
CAS No : 58258-01-8
Application : Ebastine |
|
|
|
|
AG-59 |
O-Acetyl Sallcyloyl Chloride
CAS No : 5538-51-2
Application : Nitazoxamide, Benorylate, Phenoprocoumon, Guaimesal |
|
|
|
|
AG-60 |
11-Oxo-6, 11-dihydrodibenz(b,e)-oxepin-2-acetic acid
CAS No : 55453-87-7
Application : Isoxepac, Olopatadine
|
|
|
|
|
AG-61 |
2-[4-(4-Chlorobenzoyl) phenoxy]-2-methylpropanoic acid
CAS No : 42017-89-0
Application : Fenofibrate |
|
|
|
|
AG-62 |
Cyclopropyl-2-(2-Flurophenyl) Ethanone
CAS No : 150322-73-9
Application : Prasugrel |
|
|
|
|
AG-63 |
N-[4-(Methylamino)benzyl)]-L-glutamic acid
CAS No : 52980-68-4
Application : Methotrexate |
|
|
|
|
AG-64 |
6,7-Difluoro-1-methyl-4-0x0-7(1-Piperazinyl)-1H, 4H[1,3]thiazetho[3,2-a] quinoline-3-carboxylic acid ethyl ester
CAS No : 113025-17-8
Application : Prulifloxacin |
|
|
|
|
AG-65 |
4-(Bromomethyl)-5-Methyl-1,3-dioxolan-2-one
CAS No : 80715-22-6
Application : Prulifloxacin |
|
|
|
|
AG-66 |
8-Bromo Theophyline
CAS No : 10381-75-6
Application : Pamabrom |
|
|
|
|
AG-67 |
N-(2-chloroethyl) Piperidine HCl
CAS No : 2008-75-5
Application : Flavoxate |
|
|
|
|
AG-68 |
3-Methyl Flavone-8-Carboxylic acid
CAS No : 3468-01-7
Application : Flavoxate |
|
|
|
|
AG-69 |
(+-)3-amino methyl hexanoic acid
CAS No : 130912-52-6
Application : Pregabalin |
|
|
|
|
AG-70 |
(R)-(-)3-carbomoyl methyl-5-methylhexanoic acid
CAS No : 181289-33-8
Application : Pregabalin |
|
| |
|
|
AG-71 |
3-(3-trifluoro methyl phenyl) Propionaldehyde
CAS No : 21172-41-8
Application : Cinacalcet |
|
| |
|
|
AG-72 |
(1R)-(1-Naphthyl)ethyl amine
CAS No : 3886-70-2
Application : Cinacalcet |
|
| |
|
|
AG-73 |
1-(4-amino phenyl)-4-(4-hydroxy phenyl) piperazine
CAS No : 74853-08-0
Application : Posoconazole |
|
| |
|
|
AG-74 |
2-butyl-4-chloro-1H-imidazole-5-carboxaldehyde
CAS No : 83857-96-9
Application : Losartan potassium |
|
| |
|
|
AG-75 |
[3-(dimethylamino)propyl] triphenyl phosphonium bromide hydrobromide
CAS No : 27710-82-3
Application : Olopatadine |
|
| |
|
|
AG-76 |
1-amino-2-methyl indoline Hydrochloride
CAS No : 102789-79-7
Application : Indapamide |
|
| |
|
|
AG-77 |
3-sulfomoyl-4-chloro benzoic acid
CAS No : 1205-30-7
Application : Indapamide |
|
| |
|
|
AG-78 |
Ethyl-4-(butylamino) Benzoate
CAS No : 94-32-6
Application : Benzonatat |
|
| |
|
|
AG-79 |
Poly allyl amine hydrochloride
CAS No : 71550-12-4
Application : Sevelamer |
|
| |
|
|
AG-80 |
1,4-Dihydro-2, 6-dimethyl-4-(3-nitrophenyl)-3,
5-pyridinedicarboxylic Acid 3-Methyl Ester
CAS No : 74936-72-4
Application : Lercanadipine |
|
| |
|
|
AG-81 |
N-Methyl-3, 3-diphenylpropylamine
CAS No : 28075-29-8
Application : Lercanadipine |
|
| |
|
|
AG-82 |
2, N-Dimethyl-N-(3, 3-diphenylpropyl)-1-amino-2-propanol
CAS No : 100442-33-9
Application : Lercanadipine |
|
| |
|
|
AG-83 |
2-(4-hydrodyphenyl)-4-Methylthiazole-5-carboxylic acid ethyl ester
CAS No : 161797-99-5
Application : Febuxostat |
|
| |
|
|
AG-84 |
2-(3-formyl-4-hydroxyphenyl)-4-Methylthiazole-5-carboxylic acid ethyl ester
CAS No : 161798-01-2
Application : Febuxostat |
|
| |
|
|
Kindly contact us for the requirement of other Molecules which are not listed here.
Patent infringement is the responsibility of the buyers & the Products are not offered where the valid patent is exist. |